Contact – +1-276-477-5910
Email – [email protected]

Home >> Latest Reports

LATEST REPORTS

PRESS RELEASES

The 2023-2028 World Outlook for Antiscalants-Scale Inhibitors

This study covers the world outlook for antiscalants-scale inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i...

5/10/2022 | business continuity and disaster recovery (BC/DR) solutions and services

The 2023-2028 World Outlook for Anti-Inflammatory Lupus Drugs

This study covers the world outlook for anti-inflammatory Lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i...

5/10/2022 | stem cell services

The 2023-2028 World Outlook for Anti-Icing Coating for Metals

This study covers the world outlook for anti-icing coating for metals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country i...

5/10/2022 | consumer cloud services

The 2023-2028 World Outlook for Anti-Hypertensive Diuretic Drugs

This study covers the world outlook for anti-hypertensive diuretic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the countr...

5/10/2022 | cloud gaming services

The 2023-2028 World Outlook for Anti-Aging Products and Services

This study covers the world outlook for anti-aging products and services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the countr...

5/10/2022 | anti-aging products and services

The 2023-2028 World Outlook for Anthocyanin Flavonoids

This study covers the world outlook for anthocyanin flavonoids across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of th...

5/10/2022 | over-the-top video services OTT

The 2023-2028 World Outlook for Animal Blood Plasma Cell Culture Media

This study covers the world outlook for animal blood plasma cell culture media across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the ...

5/10/2022 | virtual data room services

The 2023-2028 World Outlook for Anesthetic Pain Management

This study covers the world outlook for anesthetic pain management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is o...

5/10/2022 | clinical laboratory services

The 2023-2028 World Outlook for Anal Irrigation Systems

This study covers the world outlook for anal irrigation systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of t...

5/10/2022 | higher education services

The 2023-2028 World Outlook for Anaglyph 3D Glasses

This study covers the world outlook for anaglyph 3D glasses across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the r...

5/10/2022 | mobile and tablet streaming and download services

First
Previous
3
4
5
6
7
8
9
10
11
12
Next

This study covers the world outlook for antiscalants-scale inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of antiscalants-scale inhibitors as including all commonly understood products and/or services falling within this broad category, such as women's shoes, athletic shoes, dress shoes, winter boots, rain boots, fashion boots, slippers, and sandals that are made of leather, plastic, or fabric, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Ashland Global Holdings, Avista Technologies, BASF, BWA Water Additives, Clariant, DowDuPont, General Electric Company, Ict, Inc., Kemira Oyj, Solvay, SUEZ Water Technologies & Solutions, and The DOW Chemicalco.. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for anti-inflammatory Lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anti-inflammatory Lupus drugs as including all commonly understood products and/or services falling within this broad category, such as non-oil-based coating technology products in the dairy industry and juices, dilutables, liquid food, and household care products, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer Healthcare, Biogen, Biotest, Bristol-Myers Squibb, Celgene Corporation, F. Hoffmann-La Roche, GlaxoSmithKline, Immunomedics, Kedrion Biopharma, LFB Group, MedImmune, Merck KGaA, Novartis International, Pfizer, Shire, Takeda Pharmaceuticals Company, and UCB. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for anti-icing coating for metals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anti-icing coating for metals as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Aerospace Advanced Composites, Battelle Memorial Institute, CG2 NanoCoatings, Cytonix, DowDuPont, Ecological Coatings, Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM, Helicity Technologies, Hygratek, KISS Polymers, Nanosonic, Nbd Nano, NEI, NeverWet, Oceanit, Opus Materials Technologies, and PPG Industries. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for anti-hypertensive diuretic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anti-hypertensive diuretic drugs as including all commonly understood products and/or services falling within this broad category, such as equipment used for site illumination in procedures such as edoscopy, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Actelion Pharmaceuticals, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo Company, Johnson & Johnson, Lupin Pharmaceuticals, Merck & Company, Novartis International, Pfizer, Sanofi, and Takeda Pharmaceutical Company. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for anti-aging products and services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anti-aging products and services as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Allergan, Alma Lasers, Beiersdorf, Coty, Cynosure, Estee Lauder, Johnson & Johnson, L’Oréal, L'Oreal, Lumenis, Orlane, Personal Microderm (PMD) (Age Sciences, Inc.), Photomedex, and Solta Medical. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for anthocyanin flavonoids across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anthocyanin flavonoids as including all commonly understood products and/or services falling within this broad category, such as providers of music clip downloads taken from popular hip-hop and R&B songs which are used as cellular telephone ringtones, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Cayman Chemical Company, Extrasynthese, INDOFINE Chemical Company, Quercegen Pharmaceuticals, and Toroma Organics. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for animal blood plasma cell culture media across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of animal blood plasma cell culture media as including all commonly understood products and/or services falling within this broad category, such as ceramic, laminate, and wood non resilient flooring vinyl resilient flooring and tufted carpets and rugs, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Anzco Foods, Auckland Biosciences, Bovogen Biologicals Pty, Kraeber & Company, Lake Immunogenics, LAMPIRE Biological Laboratories, MilliporeSigma, and Thermo Fisher Scientific. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for anesthetic pain management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anesthetic pain management as including all commonly understood products and/or services falling within this broad category, such as plunger, diaphragm, and variable speed gear skids antifoam, corrosion, demulsifying, and pour-point chemical, and pH acid neutralization injection skids and skids used within the automotive, petrochemical, chemical, power, oil and gas, and water treatment industries, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include MEDNAX, North American Partners in Anesthesia, and SHERIDAN HEALTHCARE. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for anal irrigation systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anal irrigation systems as including all commonly understood products and/or services falling within this broad category, such as subscription and individual sales of weekly and monthly consumer publications, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Aquaflush Medical, B. Braun Melsungen, Becton Dickinson, Coloplast, Consure Medical, ConvaTec Group, Dentsply Sirona, HTKD Medical, MBH-International, and ProSys International. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

This study covers the world outlook for anaglyph 3D glasses across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of anaglyph 3D glasses as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include American Paper Optics, eDimensional, Epson America, LG Electronics, NVIDIA Corporation, Optoma, Panasonic Corporation, Samsung Electronics Company, Sony Corporation (Japan), and TAW-Global, LLC (Quantum 3D). In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022). ...

5/10/2022

x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT